tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AVBP Stock Latest News

ArriVent Therapeutics: Late-Stage Firmonertinib Data and Differentiated Profile Support Buy Rating and Upside Potential
RatingsArriVent Therapeutics: Late-Stage Firmonertinib Data and Differentiated Profile Support Buy Rating and Upside Potential
22d ago
AVBP
ArriVent Buy Rating: Favorable Risk‑Reward on Firmonertinib Ahead of Pivotal FURVENT Phase 3 Readout
PremiumRatings
ArriVent Buy Rating: Favorable Risk‑Reward on Firmonertinib Ahead of Pivotal FURVENT Phase 3 Readout
25d ago
AVBP
ArriVent Biopharma initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
ArriVent Biopharma initiated with an Overweight at Cantor Fitzgerald
1M ago
AVBP
ArriVent Biopharma announces first patient dosed in Phase 3 ALPACCA study
PremiumThe Fly
ArriVent Biopharma announces first patient dosed in Phase 3 ALPACCA study
2M ago
AVBP
3 ‘Strong Buy’ Stocks to Buy Today, 12/10/2025, According to Top Analysts
PremiumMarket News
3 ‘Strong Buy’ Stocks to Buy Today, 12/10/2025, According to Top Analysts
2M ago
AMZN
APGE
ArriVent Biopharma initiated with a Buy at BTIG on firmonertinib potential
PremiumThe FlyArriVent Biopharma initiated with a Buy at BTIG on firmonertinib potential
2M ago
AVBP
ArriVent Biopharma initiated with a Buy at BTIG
Premium
The Fly
ArriVent Biopharma initiated with a Buy at BTIG
2M ago
AVBP
Buy Rating for ArriVent BioPharma, Inc. Driven by Promising Developments in EGFR Exon 20 NSCLC Treatment
Premium
Ratings
Buy Rating for ArriVent BioPharma, Inc. Driven by Promising Developments in EGFR Exon 20 NSCLC Treatment
2M ago
AVBP
Buy Rating for ArriVent BioPharma Driven by Promising Firmonertinib Trial Results
PremiumRatings
Buy Rating for ArriVent BioPharma Driven by Promising Firmonertinib Trial Results
2M ago
AVBP
ArriVent Biopharma initiated with a Buy at Truist
PremiumThe Fly
ArriVent Biopharma initiated with a Buy at Truist
2M ago
AVBP
ArriVent BioPharma, Inc.: Strategic Advancements and Promising Developments Drive Buy Rating with $45 Price Target
PremiumRatings
ArriVent BioPharma, Inc.: Strategic Advancements and Promising Developments Drive Buy Rating with $45 Price Target
3M ago
AVBP
ArriVent Biopharma management to meet virtually with Clear Street
PremiumThe Fly
ArriVent Biopharma management to meet virtually with Clear Street
3M ago
AVBP
ArriVent Biopharma price target lowered to $31 from $33 at Citi
PremiumThe FlyArriVent Biopharma price target lowered to $31 from $33 at Citi
3M ago
AVBP
ArriVent BioPharma Reports Q3 2025 Financial Results
Premium
Company Announcements
ArriVent BioPharma Reports Q3 2025 Financial Results
3M ago
AVBP
ArriVent BioPharma’s Promising Trial Results and Strategic Developments Drive Buy Rating
Premium
Ratings
ArriVent BioPharma’s Promising Trial Results and Strategic Developments Drive Buy Rating
3M ago
AVBP
ArriVent Biopharma reports Q3 EPS (83c), consensus (78c)
PremiumThe Fly
ArriVent Biopharma reports Q3 EPS (83c), consensus (78c)
3M ago
AVBP
ArriVent Biopharma price target raised to $47 from $32 at Clear Street
PremiumThe Fly
ArriVent Biopharma price target raised to $47 from $32 at Clear Street
3M ago
AVBP
ArriVent BioPharma’s Phase 3 Study on Firmonertinib: A Potential Game-Changer in NSCLC Treatment
PremiumCompany Announcements
ArriVent BioPharma’s Phase 3 Study on Firmonertinib: A Potential Game-Changer in NSCLC Treatment
3M ago
AVBP
ArriVent BioPharma’s Phase 3 Study on Firmonertinib: A Potential Game-Changer in NSCLC Treatment
PremiumCompany Announcements
ArriVent BioPharma’s Phase 3 Study on Firmonertinib: A Potential Game-Changer in NSCLC Treatment
3M ago
AVBP
ArriVent Biopharma appoints Brent Rice as chief commercial officer
PremiumThe FlyArriVent Biopharma appoints Brent Rice as chief commercial officer
5M ago
AUTL
AVBP
3 Best Stocks to Buy Now, 9/10/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 9/10/2025, According to Top Analysts
5M ago
AVBP
NVDA
Premium
Ratings
ArriVent BioPharma Buy Rating: Strong Clinical Data and Strategic Positioning Highlight Potential
5M ago
AVBP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >